English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Selective Targeting of BRACA1 deficient breast cancer by bromodomain and extra-terminal motif (BET) inhibitors Conference paper
Zhang, B., Yang, E.J., Lyu, J., Liu, Y., Wu, C., Chen, Q., Tan, K., Wong, K. H., Xiaoling, X., Chuxia, D., Joong, S. S.. Selective Targeting of BRACA1 deficient breast cancer by bromodomain and extra-terminal motif (BET) inhibitors[C], 2017.
Authors:  Zhang, B.;  Yang, E.J.;  Lyu, J.;  Liu, Y.;  Wu, C.; et al.
Favorite |  | Submit date：2022/07/27
breast cancer  BRCA1  inhibitors  
Synthetic lethality screening identifies a potential role of Hsp90 in drug resistance of PTEN-deficient colorectal cancer Conference paper
Liu, Y., Yang, E.J., Zhang, B., Miao, Z., Wu, C., Lyu, J., Tan, K., Wong, K. H., Poon, C. W., Joong, S. S.. Synthetic lethality screening identifies a potential role of Hsp90 in drug resistance of PTEN-deficient colorectal cancer[C], 2017.
Authors:  Liu, Y.;  Yang, E.J.;  Zhang, B.;  Miao, Z.;  Wu, C.; et al.
Favorite |  | Submit date：2022/07/27
PTEN  tumor supressor  
Simultaneous targeting of NPC1 and VDAC1 by itraconazole leads to synergistic inhibition of MTOR signaling and angiogenesis Journal article
Head S.A., Shi W.Q., Yang E.J., Nacev B.A., Hong S.Y., Pasunooti K.K., Li R.-J., Shim J.S., Liu J.O.. Simultaneous targeting of NPC1 and VDAC1 by itraconazole leads to synergistic inhibition of MTOR signaling and angiogenesis[J]. ACS Chemical Biology, 2017, 12(1), 174.
Authors:  Head S.A.;  Shi W.Q.;  Yang E.J.;  Nacev B.A.;  Hong S.Y.; et al.
Favorite | TC[WOS]:65 TC[Scopus]:66 | Submit date：2018/10/30
Revisiting Non-Cancer Drugs for Cancer Therapy Review article
2016
Authors:  Yang E.J.;  Wu C.;  Liu Y.;  Lv J.;  Shim J.S.
Favorite | TC[WOS]:15 TC[Scopus]:15 | Submit date：2019/01/15
Cancer  Disulfiram  Doxycycline  Drug Repositioning  Existing Drugs  Mebendazole  Pyrvinium Pamoate  Triclosan  
Divergence of antiangiogenic activity and hepatotoxicity of different stereoisomers of itraconazole Journal article
Shim J.S., Li R.-J., Bumpus N.N., Head S.A., Pasunooti K.K., Yang E.J., Lv J., Shi W., Liu J.O.. Divergence of antiangiogenic activity and hepatotoxicity of different stereoisomers of itraconazole[J]. Clinical Cancer Research, 2016, 22(11), 2709-2720.
Authors:  Shim J.S.;  Li R.-J.;  Bumpus N.N.;  Head S.A.;  Pasunooti K.K.; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12 | Submit date：2019/01/15
Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism Journal article
Shim J.S., Li R.-J., Lv J., Head S.A., Yang E.J., Liu J.O.. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism[J]. Cancer Letters, 2015, 362(1), 106-115.
Authors:  Shim J.S.;  Li R.-J.;  Lv J.;  Head S.A.;  Yang E.J.; et al.
Favorite | TC[WOS]:23 TC[Scopus]:25 | Submit date：2019/01/15
Angiogenesis  Cholesterol Trafficking  Selective Estrogen Receptor Modulator  Tamoxifen